Monday, September 2, 2013
Lundbeck appeals against EU Commission fine
COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck has filed an appeal against a 93.8 million euros ($123.7 million) fine by the European Commission for deals with rivals to block the supply of generic versions of its citalopra anti-depressant to the market.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment